BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 23290789)

  • 1. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.
    Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH
    Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.
    Park MK; Lee HJ; Shin J; Noh M; Kim SY; Lee CH
    Biochim Biophys Acta; 2011 Dec; 1811(12):1021-9. PubMed ID: 21840417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
    Lee HJ; Park MK; Lee EJ; Lee CH
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to mesenchymal transition.
    Chen HH; Zhou XL; Shi YL; Yang J
    Arch Med Res; 2013 Feb; 44(2):93-8. PubMed ID: 23376055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin receptor substrate-1 suppresses transforming growth factor-beta1-mediated epithelial-mesenchymal transition.
    Shi J; Wang DM; Wang CM; Hu Y; Liu AH; Zhang YL; Sun B; Song JG
    Cancer Res; 2009 Sep; 69(18):7180-7. PubMed ID: 19738073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
    Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X
    Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway Epithelium.
    Park IH; Kang JH; Shin JM; Lee HM
    PLoS One; 2016; 11(8):e0162058. PubMed ID: 27571418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
    Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
    BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
    Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cancer cell epithelial mesenchymal transition by normal fibroblasts via production of 5-methoxytryptophan.
    Cheng HH; Chu LY; Chiang LY; Chen HL; Kuo CC; Wu KK
    Oncotarget; 2016 May; 7(21):31243-56. PubMed ID: 27145282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
    Feng H; Lu JJ; Wang Y; Pei L; Chen X
    Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
    Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
    Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
    Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
    Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
    Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.
    Kim Y; Lee EJ; Jang HK; Kim CH; Kim DG; Han JH; Park SM
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1220-8. PubMed ID: 26574150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.